Cutaneous squamous cell carcinoma in two pediatric lung transplant patients on prolonged voriconazole treatment PEDIATRIC TRANSPLANTATION Wong, J. Y., Kuzel, P., Mullen, J., Lien, D., Mahmood, M., Conrad, C., Fiorillo, L. 2014; 18 (6): E200-E207

Abstract

Oral voriconazole is commonly used for treatment and prophylaxis of invasive fungal disease post-LTx. Development of cutaneous SCC has been described in adult LTx recipients, although it is extremely rare in children. We describe two Caucasian children who developed cutaneous SCC beyond three yr post-LTx. Both developed severe photosensitivity, actinic keratosis and required curative surgical excision of the cutaneous SCC lesions. Neither patient developed metastatic lesions nor had allograft dysfunction as a result of the SCC or the change in medical treatments. The effect of voriconazole on the development of malignant skin lesions is discussed and a recommendation on dermatologic surveillance, preventive measures against phototoxicity and early treatment of SCC are provided.

View details for DOI 10.1111/petr.12320

View details for Web of Science ID 000340530800005

View details for PubMedID 25039541